Cara Therapeutics (CARA)
(Delayed Data from NSDQ)
$0.35 USD
-0.01 (-3.61%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $0.34 -0.01 (-3.63%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -0.29 |
EPS Last Quarter | -0.56 |
Last EPS Surprise | -47.37% |
ABR | 2.67 |
Earnings ESP
|
19.77% |
---|---|
Current Year | -1.28 |
Next Year | -0.77 |
EPS (TTM) | -2.25 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.26M | 1.62M | 6.63M | 6.42M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 1.88M | 2.95M | 9.94M | 12.55M |
Low Estimate | 0.90M | 0.90M | 4.80M | 3.12M |
Year ago Sales | 6.93M | 4.87M | 20.97M | 6.63M |
Year over Year Growth Est. | -81.88% | -66.82% | -68.40% | -3.06% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.29 | -0.25 | -1.28 | -0.77 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.23 | -0.23 | -1.12 | -0.34 |
High Estimate | -0.23 | -0.23 | -1.12 | -0.34 |
Low Estimate | -0.35 | -0.26 | -1.38 | -1.13 |
Year ago EPS | -0.58 | -0.52 | -2.19 | -1.28 |
Year over Year Growth Est. | 50.00% | 51.92% | 41.55% | 40.10% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 1 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 0 |
Down Last 60 Days | 0 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.29 | -0.25 | -1.28 | -0.77 |
7 Days Ago | -0.29 | -0.25 | -1.28 | -0.77 |
30 Days Ago | -0.28 | -0.22 | -1.23 | -0.88 |
60 Days Ago | -0.29 | -0.21 | -1.19 | -0.88 |
90 Days Ago | -0.24 | -0.21 | -1.03 | -0.95 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.23 | -0.23 | -1.12 | -0.34 |
Zacks Consensus Estimate | -0.29 | -0.25 | -1.28 | -0.77 |
Earnings ESP | 19.77% | 6.76% | 12.73% | 55.84% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.56 | -0.59 | -0.52 | -0.58 | NA |
Estimate | -0.38 | -0.57 | -0.53 | -0.56 | NA |
Difference | -0.18 | -0.02 | 0.01 | -0.02 | -0.05 |
Surprise | -47.37% | -3.51% | 1.89% | -3.57% | -13.14% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more